These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11312029)

  • 1. Liposome-mediated DNA vaccination: the effect of vesicle composition.
    Perrie Y; Frederik PM; Gregoriadis G
    Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-mediated DNA immunisation via the subcutaneous route.
    Perrie Y; McNeil S; Vangala A
    J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
    Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
    J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-entrapped plasmid DNA: characterisation studies.
    Perrie Y; Gregoriadis G
    Biochim Biophys Acta; 2000 Jul; 1475(2):125-32. PubMed ID: 10832026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
    de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route.
    Perrie Y; Barralet JE; McNeil S; Vangala A
    Int J Pharm; 2004 Oct; 284(1-2):31-41. PubMed ID: 15454294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-mediated DNA vaccination.
    Gregoriadis G; Saffie R; de Souza JB
    FEBS Lett; 1997 Feb; 402(2-3):107-10. PubMed ID: 9037176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
    Zuidam NJ; Barenholz Y
    Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.
    Even-Chen S; Barenholz Y
    Biochim Biophys Acta; 2000 Dec; 1509(1-2):176-88. PubMed ID: 11118529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Dutta T; Garg M; Jain NK
    Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
    Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
    Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
    Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
    Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
    Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.
    Bramwell VW; Eyles JE; Somavarapu S; Alpar HO
    Immunology; 2002 Jul; 106(3):412-8. PubMed ID: 12100730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
    Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW
    Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.